OLOPATADINE HYDROCHLORIDE 1 mg/mL Solution
by Strategic Sourcing Services LLC · 1 BOTTLE, PLASTIC in 1 CARTON (70677-1280-1) / 5 mL in 1 BOTTLE, PLASTIC
NDC 70677-1280-01
🏷️ FDA NDC (as labeled)
70677-1280-1
billing pads the package segment with a zero
OTC
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
70677-1280-1
Product NDC
70677-1280
11-digit billing NDC
70677128001
NCPDP billing unit
ML — per mL (volume)
RxCUI
1111339
UNII
2XG66W44KF
UPC
0010939961211
Application #
ANDA200810
SPL Set ID
05ab7b8d-c828-4246-b809-1eb3e4b4129f
Established class (EPC)
Histamine-1 Receptor Antagonist; Histamine-1 Receptor Inhibitor; Mast Cell Stabilizer
Mechanism of action
Histamine H1 Receptor Antagonists
Physiologic effect
Decreased Histamine Release
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2025-03-01
Route
OPHTHALMIC
Dosage form
SOLUTION
Substance
OLOPATADINE HYDROCHLORIDE
GPI-14
86802065102020
GCN Seq No
030796
GCN
68321
HICL code
012815
Ingredient (HICL)
Olopatadine Hcl
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q6
Therapeutic class — intermediate (HIC2)
Ophthalmic Preparations
HIC3 code
Q6R
Therapeutic class — specific (HIC3)
Eye Antihistamines
AHFS code
52:02.00.00
AHFS class
Antiallergic Agents
FDB label name
FT EYE ALLERGY ITCH-RED 0.1%
FDB brand name
Eye Allergy Itch-Redness Rlf
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 70677-1280-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1280-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Histamine-1 Receptor Inhibitor class.
Pharmacologic class
Histamine-1 Receptor Inhibitor, Histamine-1 Receptor Antagonist, Mast Cell Stabilizer
Drug family (ATC)
Antiallergic agents, excl. corticosteroids, Other antiallergics
How it works
Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerStrategic Sourcing Services LLC
Application holderGLENMARK PHARMACEUTICALS INC USA
FDA applicationANDA200810 (ANDA)
Labeler code70677
First marketedMar 2025
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name FT EYE ALLERGY ITCH-RED 0.1% Ingredient Olopatadine Hcl
📗 Our plain-language guide HelloPharmacist
- It does both, but with different products. The eye drops are for allergy-related itchy and red eyes. The nasal spray — brands like Patanase — is for seasonal allergic rhinitis, mea...
- What exactly does olopatadine treat — is it just for eyes, or can it help my runny nose too?
- You need to take your contacts out before you put the drops in. Wait at least 10 minutes after using the drops before you put them back in. Also, don't wear contacts at all if your...
- Can I wear my contact lenses while using olopatadine eye drops?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Olopatadine Hydrochloride ophthalmic?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $1.268 | $6.34 / 5 ml |
| Medicaid paysCMS SDUD · 12 mo | $3.40 | $17.01 / 5 ml |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 2% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Eye Allergy Itch and Redness Relief 1 mg/mL 70000-0054-01 | CARDINAL | 1 bottle | $1.221 | — | Availability likely | save 4% |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 00536-1308-40 | Rugby | 1 bottle | $1.223 | — | Discontinued | save 4% |
| Olopatadine Hydrochloride 1 mg/mL 00536-1445-40 | RUGBY | 1 bottle | $1.268 | — | Availability likely | — |
| olopatadine hydrochloride 1 mg/mL 16571-0882-05 | Rising | 5 ml | $1.268 | — | Availability likely | — |
| Olopatadine Hydrochloride Ophthalmic 1 mg/mL 43598-0765-07 | Dr. | 1 bottle | $1.268 | — | Availability likely | — |
| Olopatadine Hydrochloride 1 mg/mL 46122-0672-64 | Amerisource | 1 bottle | $1.268 | — | Availability likely | — |
| Leader Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 70000-0717-01 | CARDINAL | 1 bottle | $1.268 | — | Availability likely | — |
| Olopatadine 1 mg/mL 70069-0017-01 | Somerset | 1 bottle | $1.268 | — | Availability likely | — |
| Olopatadine Hcl 1 mg/mL 70512-0520-05 | Sola | 1 bottle | $1.268 | — | Availability likely | — |
| Eye Allergy Itch and Redness Relief 1 mg/mL 70677-1156-01 | Strategic | 1 bottle | $1.268 | — | Availability likely | — |
| Olopatadine Hydrochloride 1 mg/mLthis 70677-1280-01 | Strategic | 1 bottle | $1.268 | — | Availability likely | — |
| Pataday Twice A Day Relief 1 mg/mL 00065-4274-01 | Alcon | 1 bottle | $2.482 | — | Availability likely | +96% |
| Olopatadine Hydrochloride 1 mg/mL 62332-0501-05 | Alembic | 1 bottle | $3.065 | — | FDA listed | +142% |
| Olopatadine Hydrochloride 1 mg/mL 00363-0200-40 | WALGREEN | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 00363-0867-01 | WALGREEN | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 00363-7130-05 | Walgreens | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 11673-0689-05 | Target | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 11822-0064-01 | RITE | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 11822-9976-05 | Rite | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 24208-0966-01 | Bausch | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 30142-0064-64 | Kroger | 1 bottle | — | — | FDA listed | — |
| Eye Allergy Itch and Redness Relief Twice Daily Relief 1 mg/mL 43598-0826-07 | Dr. | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 46122-0823-29 | AmerisourceBergen | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 46708-0709-05 | Alembic | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 50090-6341-00 | A-S | 1 bottle | — | — | FDA listed | — |
| Olopatadine 1 mg/mL 50090-7959-00 | A-S | 1 bottle | — | — | FDA listed | — |
| Olopatadine hydrochloride 1 mg/mL 51407-0663-05 | Golden | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 51407-0938-05 | Golden | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution Twice Daily 1 mg/mL 55910-0109-05 | DOLGENCORP, | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 58602-0006-40 | Aurohealth | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 58602-0009-40 | Aurohealth | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 58602-0012-40 | Aurohealth | 1 bottle | — | — | FDA listed | — |
| Olopatadine hydrochloride 1 mg/mL 60505-6221-00 | Apotex | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 62332-0709-05 | Alembic | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 63868-0822-05 | Chain | 1 bottle | — | — | FDA listed | — |
| olopatadine hydrochloride ophthalmic 1 mg/mL 68083-0477-01 | Gland | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 69168-0480-02 | Allegiant | 2 bottles | — | — | FDA listed | — |
| CVS Eye Allergy Itch Relief Twice Daily 1 mg/mL 69842-0268-05 | CVS | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 72036-0008-40 | Harris | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 72476-0852-64 | Retail | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 72657-0168-50 | GLENMARK | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 76162-0020-40 | TOPCO | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 79481-1000-01 | Meijer | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 79903-0000-40 | Wal-Mart | 1 bottle | — | — | FDA listed | — |
| Equate Olopatadine Hydrochloride Ophthalmic Solution 1 mg/mL 79903-0319-01 | WAL-MART | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 82442-0966-01 | TARGET | 1 bottle | — | — | FDA listed | — |
| Olopatadine Hydrochloride 1 mg/mL 85766-0111-05 | Sportpharm | 1 bottle | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70677-1280-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q2 2025 – Q1 2026 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
983
Units reimbursed last 4 qtrs
5.2K
Gross reimbursed last 4 qtrs
$17.6K
Avg / prescription
$17.94
Avg / unit
$3.4016
Latest quarter Q1 2026
563Rx
Medicaid pays / mL
$3.4016
gross reimbursed
vs
NADAC / mL
$1.2677
acquisition cost
=
Spread
+$2.1339
+168% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 861 Rx Managed care · 122 Rx
State Medicaid map
Units reimbursed · per 100k residents
0.810.9
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 70677-1280-01 You're viewing this | 1 BOTTLE, PLASTIC in 1 CARTON (70677-1280-1) / 5 mL in 1 BOTTLE, PLASTIC | 2025-03-01 | Active |
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander
⏱️ Dosage and Administration ▾
Directions • adults and children 2 years of age and older: • put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day • if using other ophthalmic products while using this product, wait at least 5 minutes between each product • replace cap after each use • children under 2 years of age: consult a doctor
⚠️ Warnings ▾
Warnings For external use only
📦 Storage and Handling ▾
Other information • only for use in the eye • store between 4°C to 25°C (39°F to 77°F)
🧪 Active Ingredient ▾
Active Ingredient Purpose Olopatadine (0.1%). (equivalent to olopatadine hydrochloride 0.111%) Antihistamine and redness reliever
🧪 Inactive Ingredients ▾
Inactive ingredients benzalkonium chloride 0.01%, dibasic sodium phosphate, hydrochloric acid and/ or sodium hydroxide (to adjust PH), sodium chloride and water for injection.
🎯 Purpose ▾
Active Ingredient Purpose Olopatadine (0.1%). (equivalent to olopatadine hydrochloride 0.111%) Antihistamine and redness reliever
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.